UNICREDIT BANK/CALL/GSK PLC/1900/1/18.06.25 Share Price

Warrant

DE000HD1V0S9

Market Closed - BOERSE MUENCHEN 20:46:33 17/05/2024 BST
1.36 EUR -6.21% Intraday chart for UNICREDIT BANK/CALL/GSK PLC/1900/1/18.06.25
Current month+40.21%
1 month+81.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart GSK PLC
Chart UNICREDIT BANK/CALL/GSK PLC/1900/1/18.06.25
Date Price Change
17/05/24 1.36 -6.21%
16/05/24 1.45 -6.45%
15/05/24 1.55 +1.97%
14/05/24 1.52 +0.66%
13/05/24 1.51 +5.59%

Real-time BOERSE MUENCHEN

Last update May 17, 2024 at 08:46 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying GSK PLC
IssuerLogo Issuer UniCredit UniCredit
WKN HD1V0S
ISINDE000HD1V0S9
Date issued 15/01/2024
Strike 1,900 p
Maturity 18/06/2025 (397 Days)
Parity 1 : 1
Emission price 0.85
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 1.56
Lowest since issue 0.54
Spread 0.04
Spread %2.86%

Company Profile

GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. It has developed monoclonal antibodies to help treat different diseases. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes more than 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines include medicines for immune-mediated conditions. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases.
Sector
-
More about the company

Ratings for GSK plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: GSK plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
17.75 GBP
Average target price
20.32 GBP
Spread / Average Target
+14.50%
Consensus